Estimaciones de analistas de Wall Street para Sanara MedTech Inc. (SMTI): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $0.06 | ||
| 2026-08-11 | $-0.05 | $-0.03 | -100.0% |
| 2026-05-11 | $0.04 | $-0.04 | +200.0% |
| 2026-03-24 | $0.04 | $0.11 | -63.6% |
| 2025-11-12 | $0.09 | $-0.24 | +137.5% |
| 2025-08-13 | $-0.23 | $-0.33 | +30.3% |
| 2025-05-14 | $-0.41 | $-0.31 | -32.3% |
| 2025-03-25 | $-0.18 | $-0.19 | +5.3% |
Ratios de valoración
| Precio / Valor contable | 38.51 |
| EV / EBITDA | 37.56 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $5.5M | $6.3M | $5.8M | $11.8M | $15.6M | $24.1M | $45.8M | $65.0M | $86.7M | $103.1M |
| Coste de Ventas | $943579 | $806038 | $507418 | $1.2M | $1.6M | $2.3M | $6.4M | $7.9M | $8.1M | $10.2M |
| Beneficio Bruto | $4.6M | $5.5M | $5.3M | $10.6M | $14.0M | $21.8M | $39.5M | $57.1M | $78.5M | $92.9M |
| I+D | 0 | 0 | 0 | 0 | $40190 | $558704 | $3.4M | $4.1M | $5.7M | $5.1M |
| Generales y Administrativos | $4.8M | $5.3M | $5.7M | $13.1M | $18.7M | $28.1M | $46.0M | $57.0M | $76.6M | $78.7M |
| Gastos Operativos | $4.8M | $5.4M | $5.8M | $13.3M | $19.0M | $29.2M | $52.0M | $61.4M | $85.2M | $83.8M |
| Beneficio Operativo | -$272133 | $120444 | -$501860 | -$2.7M | -$5.0M | -$7.4M | -$12.5M | -$4.2M | -$6.7M | $9.1M |
| EBITDA | -$180372 | $538777 | -$417970 | -$2.6M | -$4.1M | -$7.2M | -$11.6M | -$289097 | -$1.9M | $9.0M |
| Gastos por Intereses | $174493 | $126825 | $86587 | $105919 | $11528 | $711 | $284746 | $475783 | $3.1M | $6.8M |
| Beneficio Antes de Impuestos | -$415747 | $331309 | -$600574 | -$2.8M | -$4.4M | -$8.0M | -$13.9M | -$4.4M | -$9.9M | -$393124 |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | -$5.8M | 0 | 0 | 0 |
| Beneficio Neto | -$415747 | $331309 | -$600574 | -$2.8M | -$4.4M | -$7.9M | -$7.9M | -$4.3M | -$9.7M | -$37.6M |
| BPA | $-0.38 | $0.17 | $-0.28 | $-1.37 | $-0.76 | $-1.08 | $-1.00 | $-0.52 | $-1.14 | $-4.36 |
| BPA Diluido | $-0.38 | $0.09 | $-0.28 | $-1.37 | $-0.76 | $-1.08 | $-1.00 | $-0.52 | $-1.14 | $-4.36 |
| Acciones en Circulación (Diluidas) | $1.1M | $2.1M | $2.2M | $2.1M | $5.7M | $7.3M | $7.9M | $8.3M | $8.5M | $8.6M |
Precio
| Precio | $35.09 |
| Capitalización | $323M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: HITI · LFMD · NEO · OMI · SGHT · STXS · TBRG
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de SMTI: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones